The Law Firm of Weiss & Lurie Investigates the Acquisition of Cephalon, Inc.
10 Maio 2011 - 5:50PM
Business Wire
Weiss & Lurie, a national class action and shareholder
rights law firm with offices in New York City and Los Angeles, is
investigating possible breaches of fiduciary duty and other
violations of law by the Board of Directors of Cephalon, Inc.
(NasdaqGS:CEPH) arising from its proposed acquisition by Teva
Pharmaceutical Industries Ltd. (NASDAQ:TEVA) for $81.50 per share.
The acquisition is expected to close in the third quarter of
2011.
Weiss & Lurie is investigating whether Cephalon’s Board
acted in the best interests of shareholders in approving the
transaction and whether the Board adequately shopped the Company
prior to entering into the acquisition agreement. A number of
analysts set Cephalon’s price target above the acquisition price of
$81.50 per share, with the high target being $92.
If you own Cephalon shares and would like more information about
your rights as a shareholder or additional information concerning
our investigation, please contact Julia J. Sun either by email at
info@weisslurie.com or by telephone at (888) 593-4771.
Weiss & Lurie has litigated hundreds of stockholder class
and derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for defrauded
institutions and individuals and obtained important corporate
governance in these cases. If you have information or would like
legal advice concerning possible corporate wrongdoing (such as
insider trading, waste of corporate assets, accounting fraud, or
issuing materially misleading press releases or SEC filings),
consumer fraud (such as false advertising, defective products, or
other deceptive business practices), or anti-trust violations,
please email us at info@weisslurie.com or fill out the form on our
website, http://www.weisslurie.com/contact/report_fraud/.
Attorney Advertising. Past results do not guarantee a similar
outcome.
Cephalon (NASDAQ:CEPH)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024
Cephalon (NASDAQ:CEPH)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024
Notícias em tempo-real sobre Cephalon (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Weiss & Lurie